Journal article
Recombinant FVIIa in children with liver disease
Abstract
INTRODUCTION: The aim of this study was to investigate the clinical and biochemical effects of recombinant activated factor VII (rFVIIa) in the treatment of bleeding in children with liver disease.
PATIENTS AND METHODS: 12 patients (0.3-15.9 years) with chronic liver disease were included. The indication for treatment was life threatening bleeding and failing conventional therapy (group A, 7 patients) or as prophylaxis before invasive …
Authors
Pettersson M; Fischler B; Petrini P; Schulman S; Nemeth A
Journal
Thrombosis Research, Vol. 116, No. 3, pp. 185–197
Publisher
Elsevier
Publication Date
January 2005
DOI
10.1016/j.thromres.2004.11.020
ISSN
0049-3848